TD Cowen raised the firm’s price target on Codexis to $3 from $2 and keeps a Market Perform rating on the shares. The firm raised itsd price target based on peer multiple expansion.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on CDXS:
- Codexis enters into purchase agreement with Nestle Health Science for CDX-7108
- Codexis Announces Purchase Agreement with Nestlé Health Science for CDX-7108
- Codexis enters into pruchase agreement with Nestle Health Science for CDX-7108
- Codexis and Aldevron in licensing pact for Codex HiCap RNA Polymerase
- Codexis Announces Achievement of Gram-scale Synthesis with its ECO Synthesis™ Platform
